Novel Biologicals for the Treatment of Allergic Diseases and Asthma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel Biologicals for the Treatment of Allergic Diseases and Asthma

Published:2016-09-09 Issue:10 Volume:16 Page:
ISSN:1529-7322
Container-title:Current Allergy and Asthma Reports
language:en
Short-container-title:Curr Allergy Asthma Rep

Author:

Tan Hern-Tze Tina,Sugita Kazunari,Akdis Cezmi A.

Funder

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CH)

EAACI Exchange Research

Universiti Sains Malaysia (MY)

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology

Link

http://link.springer.com/content/pdf/10.1007/s11882-016-0650-5.pdf

Reference108 articles.

1. Akdis CA. Therapies for allergic inflammation: refining strategies to induce tolerance. Nat Med. 2012;18(5):736–49. doi: 10.1038/nm.2754 .

2. Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol. 2014;133(3):621–31. doi: 10.1016/j.jaci.2013.12.1088 .

3. Muraro A, Lemanske Jr RF, Hellings PW, Akdis CA, Bieber T, Casale TB, et al. Precision medicine in patients with allergic diseases: airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2016;137(5):1347–58. doi: 10.1016/j.jaci.2016.03.010 . This is a PRACTALL consensus document that summarizes the current knowledge on major endotypes of asthma, rhinitis, and atopic dermatitis, clarifying the concepts of precision medicine, endotypes, and biomarkers, all of which are important for the management of these allergic diseases.

4. Ballow M, Akdis CA, Casale TB, Wardlaw AJ, Wenzel SE, Ballas Z, et al. Immune response modifiers in the treatment of asthma: a PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology. J Allergy Clin Immunol. 2012;130(2):311–24. doi: 10.1016/j.jaci.2012.04.046 .

5. Boyman O, Kaegi C, Akdis M, Bavbek S, Bossios A, Chatzipetrou A, et al. EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders. Allergy. 2015;70(7):727–54. doi: 10.1111/all.12616 . From the task force of biologicals of the European Academy of Allergy and Clinical Immunology (EAACI), this review highlights the currently available or tested biologicals for the treatment of various allergic diseases. They provide an overview of the efficacies of biologicals as well as the adverse side effects.

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic monoclonal antibodies in allergy: Targeting IgE, cytokine, and alarmin pathways;Immunological Reviews;2024-08-19

2. SGLT2 Inhibitors Empagliflozin and Canagliflozin Ameliorate Allergic Asthma Responses in Mice;International Journal of Molecular Sciences;2024-07-10

3. A Review on Novel Therapeutic Modalities and Evidence-based Drug Treatments against Allergic Rhinitis;Current Pharmaceutical Design;2024-04

4. The Precious Potential of the Sacred Tree Chamaecyparis obtusa (Siebold & Zucc.) Endl. as a Source of Secondary Metabolites with Broad Biological Applications;International Journal of Molecular Sciences;2024-02-27

5. Effects of Thymus quinquecostatus Celakovski on Allergic Responses in OVA-Induced Allergic Rhinitis Mice;Applied Sciences;2023-11-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3